Quick Search
-
Systematic review of existing guidelines for NAFLD assessment
Systematic Review|Published on: 7 Apr 2021 -
Guideline for stratified screening and surveillance in patients with high risk of primary liver cancer (2020)
Guideline|Published on: 25 Feb 2021
2019 
Original Articles See more
-
-
The transcontinental variability of nonalcoholic fatty liver disease
Published on: 12 Oct 2020 -
-
Robotic liver resection for hepatocellular carcinoma: a focus on anatomic resection
Published on: 7 Jan 2021
-
Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma
Published on: 12 Oct 2020
-
Validation of novel Japanese indication criteria and biomarkers among living donor liver transplantation recipients with hepatocellular carcinoma - a single center retrospective study
Published on: 21 Aug 2020
-
Distinctive magnetic resonance imaging findings of hepatocellular carcinoma after hepatitis C virus eradication with direct-acting antivirals
Published on: 26 Mar 2020
Review Articles See more
-
Revisiting the role of the hepatic vein in laparoscopic liver resection
Published on: 3 Feb 2021 -
Immunotherapy and immunotherapy biomarkers for hepatocellular carcinoma
Published on: 9 Mar 2021
-
Animal models for hepatocellular carcinoma arising from alcoholic and metabolic liver diseases
Published on: 28 Feb 2020
Other Types of Articles See more
Guideline for stratified screening and surveillance in patients with high risk of primary liver cancer (2020)
-
Laparoscopic isolated caudate lobectomy for HCC
Technical Note|Published on: 9 Apr 2021 -
Mechanisms of protective effects of astaxanthin in nonalcoholic fatty liver disease
Opinion|Published on: 9 Apr 2021 -
Laparoscopic ICG-guided RALPPS procedure for HCC on cirrhosis with 3D reconstruction implementation: a case report
Case Report|Published on: 8 Apr 2021 -
Systematic review of existing guidelines for NAFLD assessment
Systematic Review|Published on: 7 Apr 2021
Most Cited Papers In Last Two Years See more
Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma
-
Hypoalbuminemia: an underestimated, vital characteristic of hospitalized COVID-19 positive patients?
Review|Published on: 3 Jun 2020 -
-
No evidence for higher rates of hepatocellular carcinoma after direct-acting antiviral treatment: a meta-analysis
Meta-Analysis|Published on: 7 Aug 2019 -
An update on the histological subtypes of hepatocellular carcinoma
Review|Published on: 15 Nov 2019
Ongoing Special Issues See more
-
Topic: HBV Induced Hepatocellular Carcinoma and Related Potential Immunotherapy
Submission Deadline: 28 Feb 2022
Published articles: 0
-
Topic: Ongoing Debate of Entecavir vs. Tenofovir on Reducing the Risk of HCC in Patients with Chronic Hepatitis B
Submission Deadline: 18 Aug 2021
Published articles: 0
-
Topic: Clinical Management of HCC – State of the Art in 2021
Submission Deadline: 15 Jul 2021
Published articles: 0
-
Topic: The Changing Epidemiology, Surveillance and Therapy Monitoring of Hepatocellular Carcinoma
Submission Deadline: 15 Jul 2021
Published articles: 0
-
Topic: Systemic Treatment for Hepatocellular Carcinoma
Submission Deadline: 1 Jul 2021
Published articles: 0
-
Topic: HIV and Hepatitis Virus Co-infection: Risk of Hepatocellular Carcinoma
Submission Deadline: 1 Jul 2021
Published articles: 0
-
Topic: Hepatitis C Virus and Hepatocellular Carcinoma - Recent Advances
Submission Deadline: 1 Jul 2021
Published articles: 0
-
.jpg)
Topic: Genetic Variants in Development of Hepatocellular Carcinoma in Individuals with Alcohol‐related Liver Disease
Submission Deadline: 30 Jun 2021
Published articles: 0
-
Topic: Systemic Therapy for Advanced Cholangiocarcinoma: New Options on the Horizon
Submission Deadline: 30 Jun 2021
Published articles: 0
-
Topic: Minimally Invasive Therapies for HCC: the Evidence and the Future
Submission Deadline: 15 Jun 2021
Published articles: 0
-
-
Topic: Diet, Liver Diseases, Liver Cancer: Prevention from the Source
Submission Deadline: 30 Apr 2021
Published articles: 1
-
Topic - From NAFLD to MAFLD: the Dawn of a New Era?
Submission Deadline: 15 Apr 2021
Published articles: 0
-
Topic: Surgical Resection for HCC: Insights into the Indications and the Prognosis
Submission Deadline: 30 Mar 2021
Published articles: 0
-
Topic: Advances in Primary Sclerosing Cholangitis
Submission Deadline: 28 Feb 2021
Published articles: 0
-
Topic: Hepatocellular Carcinomas Developed in Patients with Metabolic Syndrome
Submission Deadline: 15 Feb 2021
Published articles: 0
-
Topic: Molecular Mechanisms of Liver Cancer Cell Proliferation, Invasion and Metastasis
Submission Deadline: 15 Feb 2021
Published articles: 0
-
Topic: Hepatoblastoma and Other Pediatric Liver Tumors
Submission Deadline: 31 Jan 2021
Published articles: 0
-
Topic: Prediction Models of Hepatocellular Carcinoma Development in Hepatitis B Patients
Submission Deadline: 31 Dec 2020
Published articles: 2
-
-
Topic: Liver Cancer and Lifestyle: Evaluation, Nutritional Status, Dietary Habits and Prognosis
Submission Deadline: 30 Nov 2020
Published articles: 1
-
Topic: Liver Transplant for HCC: Short-Term and Long-Term Problems during Follow-Up
Submission Deadline: 30 Nov 2020
Published articles: 1
-
Topic: Update on the Molecular and Genomic Classification of HCC
Submission Deadline: 31 Oct 2020
Published articles: 1
-
Topic: HBV-Induced Hepatocellular Carcinoma: Molecular and Clinical Aspects
Submission Deadline: 30 Oct 2020
Published articles: 4
-
-
Topic: Emerging Relationships between the Gut Microbiome and Liver Cancer
Submission Deadline: 15 Oct 2020
Published articles: 2
-
Topic: Prophylaxis of Hepatocellular Carcinoma
Submission Deadline: 30 Sep 2020
Published articles: 2
-
Topic: Immunotherapy and Immunotherapy Biomarkers for Hepatocellular Carcinoma
Submission Deadline: 15 Sep 2020
Published articles: 4
-
Topic: Epidemiology and Natural History of Non-Alcoholic Liver Disease
Submission Deadline: 31 Aug 2020
Published articles: 13
-
-
Topic: Living Donor Liver Transplantation for Hepatocellular Carcinoma
Submission Deadline: 15 Jun 2020
Published articles: 5
-
Topic: Role of Liver Stem Cells in the Tumorigenic Progression of Liver Cancer
Submission Deadline: 31 May 2020
Published articles: 1
Special Issue Ebooks See more
.jpg)
.jpg)
.jpg)
About The Journal
-
ISSN
2454-2520 (Online) 2394-5079 (Print)
Publisher
OAE Publishing Inc.
Article Processing Charge
$299
-
Editor-in-Chief
Guang-Wen CaoExecutive Chief Editor
Giuliano RamadoriPublishing Model
Gold Open Access
Copyright
Copyright is retained by authors
-
Publication Frequency
Continuously
Journal Data Analysis
Total publications: 356
Total article views: 1,515,210
Total article downloads: 134,516
Membership
-
COPE
Hepatoma Research is a member of the Committee on Publication Ethics (COPE) and fully adhere to its Code of Conduct and to its Best Practice Guidelines.
-
STM
Hepatoma Research (hr) is a member of and subscribes to the principles of STM. Authors of hr can reuse a certain quantity of article contents from the chargeable publications of other STM members for free in their submissions to hr.
-
ORCID
Hepatoma Research (hr) is a member of ORCID and MESAs system has been connected with ORCID. After submissions to hr are published, they will be automatically synchronized to the authors' ORCID accounts if the authors have connected their MESAs accounts with ORCID accounts. hr's reviewers can choose to synchronize their review records to their ORCID accounts when filling in review reports.
-
Crossref
Hepatoma Research is a member of Crossref, which makes research outputs easy to find, cite, link, assess, and reuse.
-
iThenticate
All submissions to Hepatoma Research are checked for plagiarism by iThenticate.
-
Check for updates
All published articles in Hepatoma Research are enriched with a record of the current article status.
Open Archives
-
Portico
All published articles will be preserved here permanently:
https://www.portico.org/
